Tebideutorexant

DB21562ExperimentalSmall molecule

Tebideutorexant is a small molecule drug. The usage of the INN stem '-orexant' in the name indicates that Tebideutorexant is a orexin receptor antagonist. Tebideutorexant has a monoisotopic molecular weight...

Formula / weight: C₂₃H₁₈F₄N₄O₂ · 460.429 g/mol (avg)

Resolves to

Compound

UNIIDQ7SMA8TWVCAS1637681-55-0ChEMBLCHEMBL4776719ChEBI758432PubChem139030979

Structure

InChIKeyHUKWIAXQBOHZIX-USKNZQBOSA-NSMILES[2H]C1([2H])[C@H]2C[C@@H](OC3=CC=C(C=N3)C(F)(F)F)[C@H](C2)N1C(=O)C1=C(C(F)=CC=C1)C1=NC=CC=N1

Targets

O43613HCRTR1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Tebideutorexant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account